⌘K

Login Start Free

Home/Filings/4/0001628280-23-000084

4//SEC Filing

Persson Magnus 4

Accession 0001628280-23-000084

CIK 0001534120other

View on SEC.gov Company Profile

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 4:13 PM ET

Size

5.3 KB

Accession

0001628280-23-000084

Insider Transaction Report

Form 4

Period: 2022-12-30

Avalo Therapeutics, Inc.AVTX

Director

Transactions

Award
Stock Option (Right to Buy)
2022-12-30+2,536→ 2,536 total
Exercise: $5.04From: 2022-12-30Exp: 2032-12-30→ Common Stock (2,536 underlying)

Footnotes (1)

[F1]100% of the stock option will immediately vest on the date that it is granted.

Documents

1 file

4
wf-form4_167278039218438.xmlPrimary
FORM 4

Issuer

Avalo Therapeutics, Inc.

CIK 0001534120

Entity typeother

Related Parties

1

filerCIK 0001653222

Filing Metadata

Form type: 4
Filed: Jan 2, 7:00 PM ET
Accepted: Jan 3, 4:13 PM ET
Size: 5.3 KB

View on SEC.gov